Epsilon Health Investors Asset Manager Profile - aVenture Research
Epsilon Health Investors is a digital healthcare-focused venture capital firm managing capital for strategic limited partners and commercial investors. The firm typically invests in seed, Series A, and Series B rounds, with a focus on innovative healthcare technology solutions. Epsilon leverages its strategic LP base and deep industry experience to support portfolio companies.
Founded by healthcare veterans Steven Epstein and Gregory Epstein of Epstein Becker & Green, P.C., Epsilon brings decades of healthcare investing, advising, regulatory support, and board leadership expertise. Notable portfolio companies include AvoMD, Axuall, and Marigold Health. The firm's unique value proposition lies in its founders' extensive relationships and industry knowledge, providing portfolio companies with strategic guidance and support.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Recorded Recipients5
Operating Recipients5
Top Investment Stages
Seed2 (40.0%)
Series A2 (40.0%)
Series B1 (20.0%)
Stage Mix
Seed 40%Series A 40%Series B 20%
Concentration shown as share of recorded participations by stage.